(Q79335078)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17089108%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

The effect of variable cigarette consumption on the interaction with clozapine and olanzapine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17089108%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

4

Espen Molden

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17089108%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

5

Helge Refsum

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17089108%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

3

Lars Tanum

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17089108%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Tore Haslemo

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17089108%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Per Haakon Eikeseth

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17089108%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

7 November 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17089108%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

21 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17089108%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17089108%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17089108%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

1049-1053

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17089108%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00228-006-0209-9

21 December 2019

exact match

0 references

cites work

Increased clozapine plasma concentrations and side effects induced by smoking cessation in 2 CYP1A2 genotyped patients

1 reference

12 December 2020

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

12 December 2020

Therapeutic monitoring of psychotropic drugs: an outline of the AGNP-TDM expert group consensus guideline

1 reference

12 December 2020

The association of weight gain and olanzapine plasma concentrations.

1 reference

12 December 2020

Sex differences in the risk of schizophrenia: evidence from meta-analysis

1 reference

12 December 2020

Are the cognitive effects of atypical antipsychotics influenced by their affinity to 5HT-2A receptors?

1 reference

12 December 2020

Effect of caffeine-containing versus decaffeinated coffee on serum clozapine concentrations in hospitalised patients

1 reference

12 December 2020

Examining concentration-dependent toxicity of clozapine: role of therapeutic drug monitoring

1 reference

12 December 2020

Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine

1 reference

12 December 2020

The effect of smoking and cytochrome P450 CYP1A2 genetic polymorphism on clozapine clearance and dose requirement

1 reference

12 December 2020

Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial

1 reference

12 December 2020

Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients

1 reference

12 December 2020

Individual changes in clozapine levels after smoking cessation: results and a predictive model

1 reference

12 December 2020

Clozapine serum concentrations are lower in smoking than in non-smoking schizophrenic patients

1 reference

12 December 2020

Therapeutic drug monitoring of olanzapine: the combined effect of age, gender, smoking, and comedication

1 reference

12 December 2020

Relationship between patient variables and plasma clozapine concentrations: a dosing nomogram.

1 reference

12 December 2020

Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine

1 reference

12 December 2020

A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors

1 reference

12 December 2020

Therapeutic drug monitoring data on olanzapine and its N-demethyl metabolite in the naturalistic clinical setting

1 reference

12 December 2020

Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine

1 reference

12 December 2020

Contributions of five human cytochrome P450 isoforms to the N-demethylation of clozapine in vitro at low and high concentrations

1 reference

12 December 2020

Effects of age and sex on olanzapine plasma concentrations

1 reference

12 December 2020

Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia.

1 reference

12 December 2020

Olanzapine. Pharmacokinetic and pharmacodynamic profile.

1 reference

12 December 2020

Smoking and schizophrenia

1 reference

12 December 2020